Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set.

scientific article

Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1039/C4CP01388C
P698PubMed publication ID24999761
P5875ResearchGate publication ID263746460

P50authorTingjun HouQ51200321
Youyong LiQ37829831
Huiyong SunQ43371037
P2093author name stringLei Xu
Sheng Tian
P2860cites workThe CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis toolsQ24248165
Comparison of simple potential functions for simulating liquid waterQ26778447
Compensating enthalpic and entropic changes hinder binding affinity optimizationQ27646075
Discovery of a Potential Allosteric Ligand Binding Site in CDK2Q27666837
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)Q27671432
Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptorsQ28219491
The impact of structural genomics: expectations and outcomesQ28292735
Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)Q29012795
Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanesQ29397708
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculationsQ29547632
Development and testing of a general amber force fieldQ29547642
Automatic atom type and bond type perception in molecular mechanical calculationsQ29616744
Exploring protein native states and large-scale conformational changes with a modified generalized born modelQ29617088
Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge modelsQ45179427
Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domainQ46098395
The implementation of a fast and accurate QM/MM potential method in AmberQ46159606
Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistanceQ46523471
Insight into crizotinib resistance mechanisms caused by three mutations in ALK tyrosine kinase using free energy calculation approachesQ47763550
Exploring the molecular basis of dsRNA recognition by Mss116p using molecular dynamics simulations and free-energy calculationsQ47911131
Comparative assessment of scoring functions on a diverse test set.Q48026800
Binding affinities of factor Xa inhibitors estimated by thermodynamic integration and MM/GBSA.Q51590039
Ligand affinities predicted with the MM/PBSA method: dependence on the simulation method and the force field.Q51930255
Influence of hyperthermophilic protein Cren7 on the stability and conformation of DNA: insights from molecular dynamics simulation and free energy analysis.Q54409858
Structural and energetic analyses of SNPs in drug targets and implications for drug therapy.Q54492091
Understanding the molecular basis of MK2-p38α signaling complex assembly: insights into protein-protein interaction by molecular dynamics and free energy studies.Q54507909
Assessing protein kinase selectivity with molecular dynamics and mm-pbsa binding free energy calculations.Q54589320
Molecular dynamics simulation, free energy calculation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors.Q54611396
Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systemsQ56750591
Binding affinities in the SAMPL3 trypsin and host–guest blind tests estimated with the MM/PBSA and LIE methodsQ56975687
The normal-mode entropy in the MM/GBSA method: effect of system truncation, buffer region, and dielectric constantQ57126949
Aqueous Solvation Free Energies of Ions and Ion−Water Clusters Based on an Accurate Value for the Absolute Aqueous Solvation Free Energy of the ProtonQ57250536
Pairwise solute descreening of solute charges from a dielectric mediumQ57250689
Parametrized Models of Aqueous Free Energies of Solvation Based on Pairwise Descreening of Solute Atomic Charges from a Dielectric MediumQ57402396
Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculationsQ58195329
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validationQ29617869
Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based modelsQ30010144
Proteome-wide detection of Abl1 SH3-binding peptides by integrating computational prediction and peptide microarrayQ30010218
Characterization of domain-peptide interaction interface: a generic structure-based model to decipher the binding specificity of SH3 domainsQ30157459
An analysis of the interactions between the Sem-5 SH3 domain and its ligands using molecular dynamics, free energy calculations, and sequence analysis.Q30168058
Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.Q30333153
The ASTRAL Compendium in 2004Q30336507
The VSGB 2.0 model: a next generation energy model for high resolution protein structure modelingQ30406909
Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent modelsQ31446320
Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistanceQ33667350
Computational alanine scanning of the 1:1 human growth hormone-receptor complexQ34120440
The experimental uncertainty of heterogeneous public K(i) data.Q34285419
The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structuresQ34323005
The PDBbind database: methodologies and updatesQ34424778
MM/GBSA binding energy prediction on the PDBbind data set: successes, failures, and directions for further improvement.Q34523014
Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulationsQ34531578
Can MM-PBSA calculations predict the specificities of protein kinase inhibitors?Q34573536
Prediction of peptides binding to the PKA RIIalpha subunit using a hierarchical strategyQ35051913
Predicting drug resistance of the HIV-1 protease using molecular interaction energy componentsQ35534782
CHARMM-GUI Ligand Binder for absolute binding free energy calculations and its applicationQ36569443
Accurate calculation of mutational effects on the thermodynamics of inhibitor binding to p38α MAP kinase: a combined computational and experimental studyQ37063817
Perspective on Free-Energy Perturbation Calculations for Chemical EquilibriaQ37426275
Free energy via molecular simulation: applications to chemical and biomolecular systemsQ38648060
Molecular dynamic investigations of the mutational effects on structural characteristics and tunnel geometry in CYP17A1.Q39318890
Accounting for ligand conformational restriction in calculations of protein-ligand binding affinitiesQ39343604
Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysisQ39505190
Explicit Ligand Hydration Shells Improve the Correlation between MM-PB/GBSA Binding Energies and Experimental Activities.Q40303491
Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from dockingQ41921801
On the use of orientational restraints and symmetry corrections in alchemical free energy calculationsQ42106721
Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435.Q43048011
Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculationQ43250372
Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA.Q43678172
Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studiesQ44290423
How well does Poisson-Boltzmann implicit solvent agree with explicit solvent? A quantitative analysisQ44474068
P433issue31
P407language of work or nameEnglishQ1860
P1104number of pages11
P304page(s)16719-16729
P577publication date2014-08-01
P1433published inPhysical Chemistry Chemical PhysicsQ3018671
P1476titleAssessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set.
P478volume16

Reverse relations

cites work (P2860)
Q51070839A fragment-based docking simulation for investigating peptide-protein bindings.
Q47400790A theoretical insight into selectivity of inhibitors toward two domains of bromodomain-containing protein 4 using molecular dynamics simulations.
Q38997273A theoretical study on the molecular determinants of the affibody protein Z(Aβ3) bound to an amyloid β peptide.
Q94211057ACID: a free tool for drug repurposing using consensus inverse docking strategy
Q92236968Abietic acid suppresses non-small-cell lung cancer cell growth via blocking IKKβ/NF-κB signaling
Q57492347Adaptive Steered Molecular Dynamics Combined With Protein Structure Networks Revealing the Mechanism of Y68I/G109P Mutations That Enhance the Catalytic Activity of D-psicose 3-Epimerase From
Q47139135Allosteric inhibitor remotely modulates the conformation of the orthestric pockets in mutant IDH2/R140Q.
Q40536980Allosteric mechanism of cyclopropylindolobenzazepine inhibitors for HCV NS5B RdRp via dynamic correlation network analysis
Q55385594An Efficient Implementation of the Nwat-MMGBSA Method to Rescore Docking Results in Medium-Throughput Virtual Screenings.
Q30238530Applications of computer-aided approaches in the development of hepatitis C antiviral agents
Q38620756Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions
Q39959298Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations
Q54323649Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring.
Q57120322Assessing the performance of MM/PBSA and MM/GBSA methods. 8. Predicting binding free energies and poses of protein-RNA complexes
Q39574481Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking
Q54294766Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study.
Q39692774BiPPred: Combined sequence- and structure-based prediction of peptide binding to the Hsp70 chaperone BiP.
Q38291300Binding free energy calculations on E-selectin complexes with sLex oligosaccharide analogs
Q92566456Binding interactions of epididymal protease inhibitor and semenogelin-1: a homology modeling, docking and molecular dynamics simulation study
Q40206445Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Cav1.2: a molecular modeling study
Q47770494Binding modes and pathway of RHPS4 to human telomeric G-quadruplex and duplex DNA probed by all-atom molecular dynamics simulations with explicit solvent
Q47348359Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study.
Q49021624Binding of ACE-inhibitors to in vitro and patient-derived amyloid-β fibril models.
Q59802679Binding of Telomestatin, TMPyP4, BSU6037, and BRACO19 to a Telomeric G-Quadruplex–Duplex Hybrid Probed by All-Atom Molecular Dynamics Simulations with Explicit Solvent
Q47735225Binding of anticancer drug daunomycin to a TGGGGT G-quadruplex DNA probed by all-atom molecular dynamics simulations: additional pure groove binding mode and implications on designing more selective G-quadruplex ligands
Q37363075Binding-affinity predictions of HSP90 in the D3R Grand Challenge 2015 with docking, MM/GBSA, QM/MM, and free-energy simulations
Q38994734Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? Assessment of Binding Site Prediction Methods and a Protocol for Validation of Predicted Binding Sites
Q90692094Carbon Nanoparticles Inhibit the Aggregation of Prion Protein as Revealed by Experiments and Atomistic Simulations
Q42364944Cas9-catalyzed DNA Cleavage Generates Staggered Ends: Evidence from Molecular Dynamics Simulations
Q48245176Cation-π interactions in CREBBP bromodomain inhibition: an electrostatic model for small-molecule binding affinity and selectivity
Q38988546Characterization of the Interaction between Gallic Acid and Lysozyme by Molecular Dynamics Simulation and Optical Spectroscopy
Q91111834Communication between the Ligand-Binding Pocket and the Activation Function-2 Domain of Androgen Receptor Revealed by Molecular Dynamics Simulations
Q38935370Computational Approaches to the Chemical Equilibrium Constant in Protein-ligand Binding
Q47362549Computational Modeling of the Hsp90 Interactions with Cochaperones and Small-Molecule Inhibitors
Q93142938Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose
Q39041742Computational identification of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120.
Q57289875Computational strategy for bound state structure prediction in structure-based virtual screening: a case study of protein tyrosine phosphatase receptor type O inhibitors
Q40962998Computational study on the drug resistance mechanism of HCV NS3 protease to BMS-605339.
Q40826753Computationally unraveling how ceritinib overcomes drug-resistance mutations in ALK-rearranged lung cancer
Q36824248Constructing and Validating High-Performance MIEC-SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery
Q92489488DLIGAND2: an improved knowledge-based energy function for protein-ligand interactions using the distance-scaled, finite, ideal-gas reference state
Q58756207Deciphering the Odorant Binding, Activation, and Discrimination Mechanism of Dhelobp21 from Dastarus Helophoroides
Q59101223Defining the Specificity of Carbohydrate–Protein Interactions by Quantifying Functional Group Contributions
Q58698253Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists
Q92923869Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity
Q39025566Dissecting the Cytochrome P450 1A2- and 3A4-Mediated Metabolism of Aflatoxin B1 in Ligand and Protein Contributions
Q52316233Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists.
Q89623468Dynamics Insights Into the Gain of Flexibility by Helix-12 in ESR1 as a Mechanism of Resistance to Drugs in Breast Cancer Cell Lines
Q51075716Effect of electrostatic polarization and bridging water on CDK2-ligand binding affinities calculated using a highly efficient interaction entropy method.
Q92581710Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations
Q37622781Effect of polarization on HIV-1protease and fluoro-substituted inhibitors binding energies by large scale molecular dynamics simulations
Q48022145Effect of sampling on BACE-1 ligands binding free energy predictions via MM-PBSA calculations
Q36061556Effect of single point mutations in a form of systemic amyloidosis.
Q57492456Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges
Q36625958Evaluating thermodynamic integration performance of the new amber molecular dynamics package and assess potential halogen bonds of enoyl-ACP reductase (FabI) benzimidazole inhibitors
Q91668311Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design
Q64115443Exploration of Catalytic Selectivity for Aminotransferase (BtrR) Based on Multiple Molecular Dynamics Simulations
Q55302171Exploring PAZ/3'-overhang interaction to improve siRNA specificity. A combined experimental and modeling study.
Q40685694Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: insight from molecular dynamics simulations and free energy calculations
Q39630932Exploring stereochemical specificity of phosphotriesterase by MM-PBSA and MM-GBSA calculation and steered molecular dynamics simulation
Q55229082Exploring the Interaction Mechanism Between Cyclopeptide DC3 and Androgen Receptor Using Molecular Dynamics Simulations and Free Energy Calculations.
Q57167603Exploring the Reasons for Decrease in Binding Affinity of HIV-2 Against HIV-1 Protease Complex Using Interaction Entropy Under Polarized Force Field
Q41667510Exploring the binding mechanisms of MIF to CXCR2 using theoretical approaches
Q47412506Exploring the influence of hyperthermophilic protein Ssh10b on the stability and conformation of RNA by molecular dynamics simulation.
Q51288369Exploring the mechanism how AF9 recognizes and binds H3K9ac by molecular dynamics simulations and free energy calculations.
Q92113799Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study
Q47272039Flavonoids as potent allosteric inhibitors of protein tyrosine phosphatase 1B: molecular dynamics simulation and free energy calculation.
Q93200393Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance
Q93016827Glucose-6-Phosphate Upregulates Txnip Expression by Interacting With MondoA
Q47250694HawkRank: a new scoring function for protein-protein docking based on weighted energy terms.
Q89834325How Different Substitution Positions of F, Cl Atoms in Benzene Ring of 5-Methylpyrimidine Pyridine Derivatives Affect the Inhibition Ability of EGFRL858R/T790M/C797S Inhibitors: A Molecular Dynamics Simulation Study
Q41490661How Does the L884P Mutation Confer Resistance to Type-II Inhibitors of JAK2 Kinase: A Comprehensive Molecular Modeling Study.
Q92002890Identification of NUDT5 Inhibitors From Approved Drugs
Q92533784Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab
Q64063487Importance of Incorporating Protein Flexibility in Molecule Modeling: A Theoretical Study on Type I NIK Inhibitors
Q41490277Importance of protein flexibility in ranking inhibitor affinities: modeling the binding mechanisms of piperidine carboxamides as Type I1/2 ALK inhibitors
Q47225930Importance of protein flexibility on molecular recognition: modeling binding mechanisms of aminopyrazine inhibitors to Nek2.
Q92619786In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4
Q64272548Increased gene copy number of worsens sepsis by inducing endothelial pyroptosis
Q92255598Indole-Containing Phytoalexin-Based Bioisosteres as Antifungals: In Vitro and In Silico Evaluation against Fusarium oxysporum
Q35871478Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations
Q48191027Influence of EGCG on α-synuclein (αS) aggregation and identification of their possible binding mode: A computational study using molecular dynamics simulation
Q61806969Insight Into the Binding Mechanism of p53/pDIQ-MDMX/MDM2 With the Interaction Entropy Method
Q89738273Insight into Ginkgo biloba L. Extract on the Improved Spatial Learning and Memory by Chemogenomics Knowledgebase, Molecular Docking, Molecular Dynamics Simulation, and Bioassay Validations
Q55220361Insight into the substrate specificity change caused by the Y227H mutation of α-glucosidase III from the European honeybee (Apis mellifera) through molecular dynamics simulations.
Q50797726Interaction mechanism exploration of R-bicalutamide/S-1 with WT/W741L AR using molecular dynamics simulations.
Q98196770Ligand-bound glutamine binding protein assumes multiple metastable binding sites with different binding affinities
Q58710194Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5
Q51144561Molecular Dynamics Studies on the Enzalutamide Resistance Mechanisms Induced by Androgen Receptor Mutations.
Q48043854Molecular basis of P450 OleTJE: an investigation of substrate binding mechanism and major pathways.
Q40374329Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors.
Q38691180Molecular dynamics investigations of membrane-bound CYP2C19 polymorphisms reveal distinct mechanisms for peripheral variants by long-range effects on the enzymatic activity.
Q38853146Molecular dynamics investigations of regioselectivity of anionic/aromatic substrates by a family of enzymes: a case study of diclofenac binding in CYP2C isoforms
Q47662738Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity.
Q51325445Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation.
Q40935601Molecular modeling study on the drug resistance mechanism of NS5B polymerase to TMC647055.
Q58699620Phosphorylation promotes binding affinity of Rap-Raf complex by allosteric modulation of switch loop dynamics
Q38764353Predicting binding modes of reversible peptide-based inhibitors of falcipain-2 consistent with structure-activity relationships.
Q114061418Predicting the mutation effects of protein–ligand interactions via end-point binding free energy calculations: strategies and analyses
Q59796192Prediction of GluN2B-CT/DAPK1 Interaction by Protein⁻Peptide Docking and Molecular Dynamics Simulation
Q47902216Prediction of luciferase inhibitors by the high-performance MIEC-GBDT approach based on interaction energetic patterns
Q64092663Probing the Behaviour of Cas1-Cas2 upon Protospacer Binding in CRISPR-Cas Systems using Molecular Dynamics Simulations
Q59799911Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18
Q89208049Quantitative surface field analysis: learning causal models to predict ligand binding affinity and pose
Q47713335Recent Developments and Applications of the MMPBSA Method
Q33572781Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis
Q35080674Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations
Q40513178Role of R292K mutation in influenza H7N9 neuraminidase toward oseltamivir susceptibility: MD and MM/PB(GB)SA study
Q41674692Statistical Analysis on the Performance of Molecular Mechanics Poisson-Boltzmann Surface Area versus Absolute Binding Free Energy Calculations: Bromodomains as a Case Study
Q92515232Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling
Q38876079Structural identification of an HER2 receptor model binding pocket to optimize lead compounds: a combined experimental and computational approach
Q91986503Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis
Q53363967Target specific proteochemometric model development for BACE1 - protein flexibility and structural water are critical in virtual screening.
Q35745162The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study
Q27012984The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Q64987688The impact of interior dielectric constant and entropic change on HIV-1 complex binding free energy prediction.
Q58119877The origin of specificity and insight into recognition between an aminoacyl carrier protein and its partner ligase
Q40377857Theoretical studies on FGFR isoform selectivity of FGFR1/FGFR4 inhibitors by molecular dynamics simulations and free energy calculations
Q48930138Theoretical studies on the selective mechanisms of GSK3β and CDK2 by molecular dynamics simulations and free energy calculations.
Q47267118To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane
Q47129892Trypsin-Ligand binding affinities calculated using an effective interaction entropy method under polarized force field.
Q35923779Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses
Q47564438Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2.
Q97086757Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors

Search more.